The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  European Journal of Cancer and Clinical Oncology

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0277-5379(86)90024-6PMID 3754515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of estrogen and progesterone receptors in primary breast cancer

  2005cited by this paper
• Estrogen receptor status as a prognostic indicator for stage I breast cancer patients

  2005cited by this paper
• Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report

  2005cited by this paper
• Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results

  2005cited by this paper
• Prognostic Significance of Progesterone Receptors Alone or in Association with Estrogen Receptors in Human Breast Cancer

  1984cited by this paper
• Estrogen receptors and long‐term prognosis in breast cancer

  1984cited by this paper
• Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.

  1984cited by this paper
• Steroid receptors and prognosis in operable (stage I and II) breast cancer.

  1983cited by this paper
• The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.

  1983cited by this paper
• Prognostic Role of Estrogen Receptor Determination in Breast Cancer

  1983cited by this paper
• Progesterone and estrogen receptors as prognostic variables in breast cancer.

  1983cited by this paper
• Estrogen receptor: A prognostic factor in breast cancer

  1981cited by this paper
• Oestrogen receptors and survival in early breast cancer.

  1981cited by this paper
• Estrogen receptor protein in breast cancer as a predictor of recurrence

  1981cited by this paper
• The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer

  1980cited by this paper
• Relationship between primary breast tumor receptor status and patient survival

  1980cited by this paper
• Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

  1977cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• WHO EMRO | Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Bayesian Approach

  2018cites this paper
• Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach.

  2017cites this paper
• A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models

  2017cites this paper
• Survival probability and prognostic factors for breast cancer patients in Vietnam

  2013cites this paper
• Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.

  2009cites this paper
• Human Cancer Xenografts Dihydropyrimidine Dehydrogenase Activities in Tumors in Doxifluridine and the Ratio of Thymidine Phosphorylase to Positive Correlation between the Efficacy of Capecitabine and Updated Version

  2006cites this paper
• The relationship of estrogen receptor status to DNA ploidy in breast cancer

  2004cites this paper
• Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.

  1998cites this paper
• Les traitements adjuvants du cancer du sein précoce sans atteinte ganglionnaire

  1994cites this paper
• [Adjuvant treatments of early breast cancer without lymph node involvement].

  1994cites this paper
• Conservative treatment of early breast cancer: what is important?

  1994cites this paper
• Chemotherapy for Node-Negative Breast Cancer

  1993cites this paper
• The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.

  1993cites this paper
• Defining the high-risk breast cancer patient.

  1992cites this paper
• Endocrine Therapy of Breast Cancer V

  1992cites this paper
• Hormone receptors in malignancy.

  1992cites this paper
• Prognostic Factors in Primary Breast Cancer: Second Thoughts

  1992cites this paper
• Prognostic indicators in node-negative early stage breast cancer.

  1992cites this paper
• Preoperative systemic treatment of large operable primary breast carcinoma : relationship between tumour characteristics and response to therapy

  1992cites this paper
• Steroid receptors in breast cancer

  1991cites this paper
• Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene

  1990cites this paper
• How to use prognostic factors in axillary node-negative breast cancer patients.

  1990cites this paper
• Estimation of epidermal growth factor receptor in 177 breast cancers: Correlation with prognostic factors

  1990cites this paper
• Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay

  1990cites this paper
• Predicting distant metastases in operable breast cancer patients

  1990cites this paper
• Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients.

  1989cites this paper
• Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy

  1988cites this paper
• The clinical biology of hormone-responsive breast cancer.

  1988cites this paper
• Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis

  1988cites this paper
• Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

  1988cites this paper
• [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].

  1988cites this paper
• Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance.

  1988cites this paper
• Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.

  1987cites this paper
• [Prognostic value of estradiol and progesterone receptors in stage I and II breast cancer with an adjuvant treatment].

  1987cites this paper
• Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

  1987cites this paper
• Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

  1987cites this paper